Applying Artificial Intelligence to Gynecologic Oncology: A Review

被引:1
作者
Mysona, David Pierce [1 ]
Kapp, Daniel S. [2 ]
Rohatgi, Atharva [3 ]
Lee, Danny [4 ]
Mann, Amandeep K. [5 ]
Tran, Paul [6 ]
Tran, Lynn [6 ]
She, Jin-Xiong [6 ]
Chan, John K. [7 ]
机构
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA
[3] Univ Calif Davis, Davis, CA 95616 USA
[4] Univ Calif Berkeley, Berkeley, CA 94720 USA
[5] Palo Alto Med Fdn Res Inst, Palo Alto, CA USA
[6] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA
[7] Palo Alto Med Fdn Res Inst, Gynecol Oncol, Palo Alto, CA USA
关键词
LYMPH-NODE METASTASIS; NEURAL-NETWORKS; OVARIAN-CANCER; RADICAL HYSTERECTOMY; RISK-FACTORS; CLASSIFICATION; DISCRIMINATION; BENIGN; PREDICTION; DIAGNOSIS;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Importance: Artificial intelligence (AI) will play an increasing role in health care. In gynecologic oncology, it can advance tailored screening, precision surgery, and personalized targeted therapies. Objective: The aim of this study was to review the role of AI in gynecologic oncology. Evidence Acquisition: Artificial intelligence publications in gynecologic oncology were identified by searching "gynecologic oncology AND artificial intelligence" in the PubMed database. A review of the literature was performed on the history of AI, its fundamentals, and current applications as related to diagnosis and treatment of cervical, uterine, and ovarian cancers. Results: A PubMed literature search since the year 2000 showed a significant increase in oncology publications related to AI and oncology. Early studies focused on using AI to interrogate electronic health records in order to improve clinical outcome and facilitate clinical research. In cervical cancer, AI algorithms can enhance image analysis of cytology and visual inspection with acetic acid or colposcopy. In uterine cancers, AI can improve the diagnostic accuracies of radiologic imaging and predictive/prognostic capabilities of clinicopathologic characteristics. Artificial intelligence has also been used to better detect early-stage ovarian cancer and predict surgical outcomes and treatment response. Conclusions and Relevance: Artificial intelligence has been shown to enhance diagnosis, refine clinical decision making, and advance personalized therapies in gynecologic cancers. The rapid adoption of AI in gynecologic oncology will depend on overcoming the challenges related to data transparency, quality, and interpretation. Artificial intelligence is rapidly transforming health care. However, many physicians are unaware that this technology is being used in their practices and could benefit from a better understanding of the statistics and computer science behind these algorithms. This review provides a summary of AI, its applicability, and its limitations in gynecologic oncology. Target Audience: Obstetricians and gynecologists, family physicians Learning Objectives: After completing this CME activity, physicians should be better able to describe the basic functions of AI algorithms; explain the potential applications of machine learning in diagnosis, treatment, and prognostication of cervical, endometrial, and ovarian cancers; and identify the ethical concerns and limitations of the use of AI in the management of gynecologic cancer patients.
引用
收藏
页码:292 / 301
页数:10
相关论文
共 92 条
[1]  
[Anonymous], 1997, An artificial neural networks primer with financial applications examples in financial distress predictions and foreign exchange hybrid trading system
[2]  
[Anonymous], 2017, INTRADOGLOBAL NEWSWI
[3]  
[Anonymous], Understanding the real capabilities of unsupervised machine learning
[4]  
[Anonymous], GETFITNESSAI
[5]   Artificial Intelligence Poised to Ride a New Wave [J].
Anthes, Gary .
COMMUNICATIONS OF THE ACM, 2017, 60 (07) :19-21
[6]   ULTRASOUND IMAGE DISCRIMINATION BETWEEN BENIGN AND MALIGNANT ADNEXAL MASSES BASED ON A NEURAL NETWORK APPROACH [J].
Aramendia-Vidaurreta, Veronica ;
Cabeza, Rafael ;
Villanueva, Arantxa ;
Navallas, Javier ;
Luis Alcazary, Juan .
ULTRASOUND IN MEDICINE AND BIOLOGY, 2016, 42 (03) :742-752
[7]  
Baker J, 1992, P WORKSH SPEECH NAT, P471
[8]  
Barry-Straume Jostein., 2018, SMU Data Sci. Rev, V1, P12
[10]   Cognitive technology addressing optimal cancer clinical trial matching and protocol feasibility in a community cancer practice. [J].
Beck, J. Thaddeus ;
Vinegra, Michael ;
Dankwa-Mullan, Irene ;
Torres, Adam ;
Simmons, Courtney C. ;
Holtzen, Helen ;
Urman, Alexandra ;
Roper, Nancy ;
Norden, Andrew D. ;
Rammage, Melissa ;
Hancock, Steven ;
Lim, Kyungae ;
Rao, Prasanna ;
Coverdill, Sadie ;
Roberts, Louisa ;
Williamson, Paul ;
Howell, Mickey ;
Chau, Quincy ;
Culver, Kenneth W. ;
Sweetman, Robert William .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35